Kaori Morota

Summary

Affiliation: Abbott Laboratories
Country: USA

Publications

  1. doi request reprint Improvement and multicenter evaluation of the analytical performance of an automated chemiluminescent immunoassay for alpha fetoprotein
    Kaori Morota
    Research and Development, Abbott Japan Co, Ltd, Matsudo, Chiba Japan
    Int J Biol Markers 27:39-46. 2012
  2. doi request reprint A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen
    Kaori Morota
    Abbott Japan, Matsudo, Chiba, Japan
    J Virol Methods 157:8-14. 2009
  3. doi request reprint A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma
    Kaori Morota
    Research and Development, Abbott Japan Co, Ltd, Matsudo, Chiba, Japan
    Clin Chem Lab Med 49:711-8. 2011

Detail Information

Publications3

  1. doi request reprint Improvement and multicenter evaluation of the analytical performance of an automated chemiluminescent immunoassay for alpha fetoprotein
    Kaori Morota
    Research and Development, Abbott Japan Co, Ltd, Matsudo, Chiba Japan
    Int J Biol Markers 27:39-46. 2012
    ..In addition, this reformulation eliminated the possibility of falsely depressed samples at high AFP concentrations. The purpose of this study was to evaluate its analytical performance at multiple sites...
  2. doi request reprint A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen
    Kaori Morota
    Abbott Japan, Matsudo, Chiba, Japan
    J Virol Methods 157:8-14. 2009
    ..8% by testing 5403 specimens from US volunteer blood donors, hospitalized patients and individuals with medical conditions unrelated to HCV infection, in addition to specimens containing potentially interfering substances...
  3. doi request reprint A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma
    Kaori Morota
    Research and Development, Abbott Japan Co, Ltd, Matsudo, Chiba, Japan
    Clin Chem Lab Med 49:711-8. 2011
    ....